Web4 jun. 2024 · Published: Jun 04, 2024. June 4, 2024 13:22 UTC. Tetraphase terminates merger agreement with AcelRx to enter into merger agreement with Melinta. Melinta agreement provides for an aggregate of $39.0 million upfront in cash plus potential contingent value rights cash payments of up to $16.0 million. Acquisition Expected to … WebBarr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.. Approximately 75% of the company's revenues were from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.. It was acquired by Teva Pharmaceutical Industries in 2008 for an estimated 7.46 …
Homepage - Melinta
WebMarket Capitalization, $M 6 5-Day Change -0.0850 -16.19% ALL Full Chart Press & news More Stories Melinta Therapeutics Announces Termination of Merger Agreement and … WebExperienced Biotech Executive delivering key business and R&D initiatives in the field of cancer immunotherapy including cellular therapies and anti-infectives for more than 10 years. Currently serves as group CFO and member of the Executive Board AiCuris employees and the Board of Directors. In that role Sabrina is responsible for Corporate … show running services powershell
Crisis Looms in Antibiotics as Drug Makers Go Bankrupt
Web20 apr. 2024 · Melinta Therapeutics' mailing address is 44 WHIPPANY ROAD, MORRISTOWN NJ, 07960. The official website for the company is www.melinta.com. … WebMelinta Therapeutics Market Capitalization is currently at 6.88 M. Market Capitalization is the total market value of Melinta Therapeutics' equity. It is one of many ways to … WebInteractive chart of historical net worth (market cap) for Melinta Therapeutics (MLNTQ) over the last 10 years. How much a company is worth is typically represented by its … show running services ubuntu